Inventor · disambiguated record
David Cousin
Also filed as: COUSIN DAVID
11 granted patents·16 pending applications·23 citations·filing 2008–2025
85Inventor score
Files withSTEP PHARMA S A S7SITRYX THERAPEUTICS LTD6OTSUKA PHARMA CO LTD4ASTEX THERAPEUTICS LTD2ENYO PHARMA2
Top patents by PatentIndex Score
27 records- 0192US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 0291US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 0382US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0479US11603367B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2018·Granted Mar 14, 2023·2 cites·12 claims
- 0574US10118920B2Isoxazolyl substituted benzimidazolesCELLCENTRIC LTD·Filed 2016·Granted Nov 6, 2018·2 cites·16 claims
- 0673US11655246B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2018·Granted May 23, 2023·1 cites·19 claims
- 0772US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
- 0871US9024018B23-substituted-8-substituted-3H-imidazo[5,1-d][1,2,3,5]tetrazin-4-one compounds and their useHUMMERSONE MARC GEOFFERY·Filed 2010·Granted May 5, 2015·3 cites·39 claims
- 0971US8450479B23-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5-tetrazine-8-carboxylic acid amides and their useSTEVENS MALCOLM FRANCIS GRAHAM·Filed 2008·Granted May 28, 2013·6 cites·38 claims
- 1070US2025074900A1Isoindolinone inhibitors of the mdm2-p53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1158US2023192673A1CompoundsSTEP PHARMA S A S·Filed 2022·Application pending·0 cites
- 1257US12466810B2N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 1355US12448367B2Phthalazine derivatives as pyruvate kinase modulatorsSITRYX THERAPEUTICS LTD·Filed 2025·Granted Oct 21, 2025·0 cites·26 claims
- 1454US2024409542A1Novel compoundsSITRYX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1552US2024245691A12-methylene-4-oxo-butanoic acid derivatives for the treatment of inflammationSITRYX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1650US2022251028A1Tertiary amine derivatives and their uses for treating a viral infectionENYO PHARMA·Filed 2020·Application pending·0 cites
- 1750US2025051313A1Phthalazine derivatives as pyruvate kinase modulatorsSITRYX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1849US2023020663A1Sulfonamide inhibitors as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1948US2023150978A1Quinazolinone derivatives and uses thereof for treating a cancerENYO PHARMA·Filed 2021·Application pending·0 cites
- 2048US2023002352A1Sulfonamide derivatives as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 2147US2023086703A1N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 2243US12390437B2Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune responseSITRYX THERAPEUTICS LTD·Filed 2020·Granted Aug 19, 2025·0 cites·11 claims
- 2343US2023219907A1Carboxy derivatives with antiinflamatory propertiesSITRYX THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2441US2021024507A1CompoundsSTEP PHARMA S A S·Filed 2019·Application pending·0 cites
- 2540US2013338104A13-Substituted-4-Oxo-3,4-Dihydro-Imidazo[5,1-d]1,2,3,5-Tetrazine-8-Carboxylic Acid Amides and Their UsePHARMINOX LTD·Filed 2013·Application pending·0 cites
- 2634US2013012706A1Methods and Intermediates for the Synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazinesPHARMINOX LTD·Filed 2011·Application pending·0 cites
- 2728US2013310411A1Novel acridine derivativesHUMMERSONE MARC GEOFFERY·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Cousin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →